Abstract
Enhancers of endocannabinoid signaling are potential analgesics, but they cause unacceptable psychiatric side effects. A new study reports an inhibitor of endocannabinoid breakdown that has analgesic activity and cannot enter the CNS.
MeSH terms
-
Animals
-
Brain / drug effects
-
Brain / metabolism
-
Cannabinoid Receptor Modulators / metabolism*
-
Cannabinoid Receptor Modulators / therapeutic use*
-
Endocannabinoids*
-
Pain / drug therapy*
-
Pain / metabolism*
-
Peripheral Nervous System / drug effects*
-
Peripheral Nervous System / metabolism
Substances
-
Cannabinoid Receptor Modulators
-
Endocannabinoids